Nanopulse Efficacy Study for the Treatment of Common Warts
Sponsor: University of Southern California
Listed as NCT02650466, this NA trial focuses on Common Warts and remains completed. Sponsored by University of Southern California, it has been updated 7 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Sep 2019 — Jan 2021 [monthly]
Completed NA
-
Jun 2018 — Sep 2019 [monthly]
Completed NA
▶ Show 2 earlier versions
-
Apr 2017 — Jun 2018 [monthly]
Completed NA
Status: Recruiting → Completed
-
Jan 2017 — Apr 2017 [monthly]
Recruiting NA
First recorded
Dec 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Southern California
For direct contact, visit the study record on ClinicalTrials.gov .